Effect of liposomal encapsulated superoxide dismutase on patients with Kawasaki disease.
Somiya
K
K
Department of Pediatrics, Hamamatsu Medical Center.
Niwa
Y
Y
Fukami
S
S
Michelson
A M
AM
D001241:Aspirin / Q000627:therapeutic use; D002675:Child, Preschool; D003323:Coronary Aneurysm / Q000517:prevention & control; D006801:Humans; D007116:Immunization, Passive; D007223:Infant; D008081:Liposomes / Q000008:administration & dosage*; D009080:Mucocutaneous Lymph Node Syndrome / Q000628:therapy*; D013482:Superoxide Dismutase / Q000627:therapeutic use*
D008081:Liposomes; D013482:Superoxide Dismutase; D001241:Aspirin